Fundraising Fox

Auron Therapeutics

Newton, US · Founded 2018 · 1 known investors

aurontherapeutics.com ↗
Biotech

Founders & leadership

CG
Christopher GuiffreExecutive Officer
AL
Alon LazarusDirector
AF
Anna FrenchDirector
KY
Katharine YenExecutive Officer, Director
VR
Victoria RichonDirector
BD
Briggs Duncan MorrisonDirector
AC
Alexandra CantleyDirector
ES
Eric ShiozakiDirector

Investors · 1

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

Reported raises · per SEC filings

Form D private placements
▶$27.3MraisedDec 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Briggs Duncan MorrisonDirector
  • Pini OrbachDirector
  • Katharine YenExecutive Officer, Director
  • Alexandra CantleyDirector
  • Victoria RichonDirector
  • Anna FrenchDirector
  • Serge MesserlianDirector
Offering amount
$42.3M
Amount sold
$27.3M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.4MraisedOct 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher GuiffreExecutive Officer
  • Alon LazarusDirector
  • Anna FrenchDirector
  • Katharine YenExecutive Officer, Director
  • Victoria RichonDirector
  • Briggs Duncan MorrisonDirector
  • Alexandra CantleyDirector
  • Eric ShiozakiDirector
Offering amount
$48.2M
Amount sold
$38.4M
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.4MraisedDec 2020 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac CiechanoverDirector
  • Katharine YenExecutive Officer, Director
  • John Duncan HiggonsDirector
  • Alon LazarusDirector
  • Anna FrenchDirector
Offering amount
$15.4M
Amount sold
$15.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$660KraisedJul 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Katharine YenExecutive Officer, Director
  • John Duncan HiggonsDirector
Offering amount
$1.5M
Amount sold
$660K
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.